Quantcast

Latest Rosiglitazone Stories

2014-08-22 23:06:12

More Than 5,000 Cases Now Being Handled in Massachusetts (PRWEB) August 22, 2014 According to a July 15 article in the Boston Herald, the number of lawsuits involving the use of dialysis products GranuFlo and NaturaLyte being heard in two Massachusetts courts now exceeds 5,000, the national law firm of Baron and Budd reports. The plaintiffs allege that the manufacturer of these products, Fresenius Medical Care – which also owns thousands of dialysis clinics across the United States –...

2014-07-17 04:21:04

MT Services LLC informs plaintiffs on various pharmaceutical drug cases available to obtain lawsuit funding and legal assistance BRONX, N.Y., July 17, 2014 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company, which operates lawsuitsettlementnews.com announced today a primary focus on assisting plaintiffs of bad pharmaceutical drugs such as AndgroGel: Testosterone Creams, Accutane, Acetaminophen, Actos, Avandia, Byetta-Januvia-Victoza, Birth Control Products:...

2014-06-27 23:07:53

GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs. Flood Law Group is investigating potential Paxil claims in light of this recent settlement. (PRWEB) June 27, 2014 GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs,...

2014-06-13 23:03:53

Bellwether Trial Expected to Begin in July 2015 ST. LOUIS, MI (PRWEB) June 13, 2014 Multidistrict litigation (MDL) is continuing to progress in cases involving Lipitor, a cholesterol-lowering medication that has been linked to the development of type 2 diabetes, reports the national law firm of Baron and Budd. So far, more than 130 lawsuits have been transferred to the MDL. The lawsuits allege that the maker of Lipitor, Pfizer, either knew about the risk of diabetes or should have known...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...

2014-02-17 23:21:07

Scientists find a “modest but clinically significant” link between the diabetes drug and bladder cancer. Raleigh, NC (PRWEB) February 17, 2014 The authors of a new study published in the British Journal of Clinical Pharmacology and detailed by Cancer Monthly recommend that doctors who treat diabetes limit their patients’ exposure to the drug piaglitazone (Actos) to reduce their risk of bladder cancer. The research team from Liverpool conducted a search of the medical literature for...

diabetes med affects men's and women's hearts differently
2013-12-12 15:24:01

Brett Smith for redOrbit.com - Your Universe Online In a new study from researchers at at Washington University School of Medicine, the type 2 diabetes drug metformin was found to have different effects on the hearts of men and women, despite managing blood sugar the same in both sexes. According to the study, which was published in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology, the drug had positive effects on women’s heart health, but...

Diabetes Medication Reduces Cancer Risk
2013-12-06 14:45:10

Brett Smith for redOrbit.com - Your Universe Online A study led by researchers at the Cleveland Clinic has found a certain class of oral medications used to treat type 2 diabetes reduces the risk of female patients also developing cancer. Cancer is more common in patients with diabetes than in those without the condition and women with diabetes appear to be at a high risk of breast cancer and cancers of the reproductive tract. Many cancer cells have also been found to have receptors for...

2013-10-22 11:00:30

A new report by researchers from Harvard University and others in a working group convened by the Multi-Regional Clinical Trials Center (MRCT) at Harvard proposes recommendations for addressing a problem that has vexed drug regulators: how to expand public access to data from clinical trials while protecting patients' privacy and weighing pharmaceutical companies' business interests. Recently, the European Medicines Agency (EMA) announced it will provide public access to participant-level...

2013-08-20 23:19:23

Lawsuits Consolidated in Multidistrict Litigation, Will Help Efficiency of Cases LOS ANGELES (PRWEB) August 20, 2013 Burton LeBlanc, shareholder at the national plaintiffs’ law firm of Baron and Budd, has been selected to sit on the Plaintiffs’ Steering Committee (PSC) in the legal matters surrounding GranuFlo and its sister product NaturaLyte. This committee works to protect the rights of people who have filed lawsuits against Fresenius for health issues allegedly linked to GranuFlo...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related